Eva Rödel

Title: Eva Rödel: Innovator in Crystalline Diacylhydrazine

Introduction

Eva Rödel is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of chemistry, particularly in the development of crystalline diacylhydrazine compounds. With a total of 3 patents to her name, her work has implications for gene expression regulation.

Latest Patents

Rödel's latest patents focus on crystalline polymorphic and amorphous forms of specific compounds. These include (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N'-(2-ethyl-3-methoxy-benzoyl)-hydrazide (Compound 1) and (S)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N'-(2-ethyl-3-methoxy-benzoyl)-hydrazide (Compound 2). The disclosures provide methods for creating these forms and their applications in regulating gene expression in cells or subjects.

Career Highlights

Throughout her career, Eva Rödel has worked with notable companies such as Intrexon Corporation and BASF SE. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in her field.

Collaborations

Rödel has collaborated with esteemed colleagues, including Robert Eugene Hormann and Inna Shulman. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Eva Rödel's contributions to the field of chemistry, particularly through her patents on crystalline diacylhydrazine, highlight her role as an influential inventor. Her work continues to pave the way for advancements in gene expression regulation.